Searching for the 1 in 2,400,000: A review of dystrophin gene point mutations

The past few years have seen a rapid increase in our knowledge of naturally occurring mutations in the dystrophin gene. Although earlier studies were limited to gross rearrangement mutations, we are now in a position to draw lessons on the molecular etiology of the remaining one‐third of cases of Duchenne and Becker muscular dystrophy (DMD, BMD) which are associated with small mutations. This paper reviews 70 published and unpublished small mutations in the dystrophin gene and asks what we can learn about their nature, their distribution, and approaches to their characterisation. Strikingly for such a well‐conserved gene, missense mutations are extremely rare, and the vast majority of DMD point mutations, like the gross rearrangements, result in premature translational termination. It seems increasingly likely that almost all cases of DMD arise solely as a result of a reduction in the level of dystrophin transcripts, and we argue that >95% of DMD mutations contribute nothing to the functional dissection of the dystrophin protein. Most of the few BMD point mutations presented here are missense mutations in the N‐terminal or C‐terminal domains or are splice‐site mutations that probably act, like BMD deletions, via the production of in‐frame, interstitially deleted transcripts. © 1994 Wiley‐Liss, Inc.

[1]  A. Speer,et al.  Carrier detection in DMD families with point mutations, using PCR-SSCP and direct sequencing , 1994, Neuromuscular Disorders.

[2]  J. Mendell,et al.  Heteroduplex analysis of the dystrophin gene: application to point mutation and carrier detection. , 1994, American journal of medical genetics.

[3]  N. Laing,et al.  Identification of a point mutation and germinal mosaicism in a duchenne muscular dystrophy family , 1994, Human mutation.

[4]  Y. Takeshima,et al.  A novel point mutation (G-1 to T) in a 5' splice donor site of intron 13 of the dystrophin gene results in exon skipping and is responsible for Becker muscular dystrophy. , 1994, American journal of human genetics.

[5]  O. Ibraghimov-Beskrovnaya,et al.  Primary structure and muscle-specific expression of the 50-kDa dystrophin-associated glycoprotein (adhalin). , 1993, The Journal of biological chemistry.

[6]  K. Campbell,et al.  Genetic heterogeneity for Duchenne-like muscular dystrophy (DLMD) based on linkage and 50 DAG analysis. , 1993, Human molecular genetics.

[7]  H. Thiele,et al.  Point mutations at the carboxy terminus of the human dystrophin gene: implications for an association with mental retardation in DMD patients. , 1993, Human molecular genetics.

[8]  I. Grunewald,et al.  Non-isotopic analysis of single strand conformation polymorphism (SSCP) in the exon 13 region of the human dystrophin gene. , 1993, Journal of medical genetics.

[9]  J. D. den Dunnen,et al.  Protein truncation test (PTT) for rapid detection of translation-terminating mutations. , 1993, Human molecular genetics.

[10]  M. Grompe,et al.  The rapid detection of unknown mutations in nucleic acids , 1993, Nature genetics.

[11]  J. Mendell,et al.  A missense mutation in the dystrophin gene in a Duchenne muscular dystrophy patient , 1993, Nature Genetics.

[12]  A. Hamosh,et al.  Nonsense mutations and diminished mRNA levels , 1993, Nature Genetics.

[13]  N. Laing,et al.  Two distinct mutations in a single dystrophin gene: identification of an altered splice-site as the primary Becker muscular dystrophy mutation. , 1993, American journal of medical genetics.

[14]  C. Mathew,et al.  A nonsense mutation and exon skipping in the Fanconi anaemia group C gene. , 1993, Human molecular genetics.

[15]  D. Bentley,et al.  Exon structure of the human dystrophin gene. , 1993, Genomics.

[16]  L. Kunkel,et al.  An alternative dystrophin transcript specific to peripheral nerve , 1993, Nature Genetics.

[17]  V. Chapman,et al.  New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin , 1993, Nature Genetics.

[18]  Seymour,et al.  Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect. , 1993, The Journal of clinical investigation.

[19]  J. Mendell,et al.  Identification of two point mutations and a one base deletion in exon 19 of the dystrophin gene by heteroduplex formation. , 1993, Human molecular genetics.

[20]  L. Maquat,et al.  Nonsense codons can reduce the abundance of nuclear mRNA without affecting the abundance of pre-mRNA or the half-life of cytoplasmic mRNA. , 1993, Molecular and cellular biology.

[21]  David Valle,et al.  The skipping of constitutive exons in vivo induced by nonsense mutations , 1993, Science.

[22]  L. Maquat,et al.  Evidence to implicate translation by ribosomes in the mechanism by which nonsense codons reduce the nuclear level of human triosephosphate isomerase mRNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Passos-Bueno,et al.  Point mutation in a Becker muscular dystrophy patient. , 1993, Human molecular genetics.

[24]  D. Bentley,et al.  Infidelity in the structure of ectopic transcripts: A novel exon in lymphocyte dystrophin transcripts , 1993, Human mutation.

[25]  L. Morandi,et al.  A novel nonsense mutation in the human dystrophin gene , 1993, Human mutation.

[26]  J. Mendell,et al.  Exon 44 nonsense mutation in two‐duchenne muscular dystrophy brothers detected by heteroduplex analysis , 1993, Human mutation.

[27]  A. Hamosh,et al.  CFTR nonsense mutations G542X and W1282X associated with severe reduction of CFTR mRNA in nasal epithelial cells. , 1992, Human molecular genetics.

[28]  G. Puca,et al.  Detection of a nonsense mutation in the dystrophin gene by multiple SSCP. , 1992, Human molecular genetics.

[29]  R. Gibbs,et al.  Identification of a 2 base pair nonsense mutation causing a cryptic splice site in a DMD patient. , 1992, Human molecular genetics.

[30]  K. Campbell,et al.  Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy , 1992, Nature.

[31]  C. Caskey,et al.  Premature chain termination mutation causing Duchenne muscular dystrophy , 1992, Neurology.

[32]  Hideko Yamamoto,et al.  Glycoprotein‐binding site of dystrophin is confined to the cysteine‐rich domain and the first half of the carboxy‐terminal domain , 1992, FEBS letters.

[33]  G. Danieli,et al.  A 3' consensus splice mutation in the human dystrophin gene detected by a screening for intra-exonic deletions. , 1992, Human molecular genetics.

[34]  D. Bentley,et al.  Determination of the exon structure of the distal portion of the dystrophin gene by vectorette PCR. , 1992, Genomics.

[35]  R. Bartlett,et al.  An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. , 1992, Genomics.

[36]  L. Elsas,et al.  Reduced mRNA and a nonsense mutation in the insulin-receptor gene produce heritable severe insulin resistance. , 1992, American journal of human genetics.

[37]  K. Davies,et al.  Characterization of a 4.8kb transcript from the Duchenne muscular dystrophy locus expressed in Schwannoma cells. , 1992, Human molecular genetics.

[38]  C. Caskey,et al.  Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development. , 1992, Nucleic acids research.

[39]  S. Baserga,et al.  Beta-globin nonsense mutation: deficient accumulation of mRNA occurs despite normal cytoplasmic stability. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  H. Steingrimsdottir,et al.  Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene. , 1992, Nucleic acids research.

[41]  D. Bentley,et al.  Point mutations in the dystrophin gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  S. O’Brien,et al.  Detecting single base substitutions as heteroduplex polymorphisms. , 1992, Genomics.

[43]  R. Weleber,et al.  Nonsense-codon mutations of the ornithine aminotransferase gene with decreased levels of mutant mRNA in gyrate atrophy. , 1992, American journal of human genetics.

[44]  Jamel Chelly,et al.  Illegitimate transcription: Its use in the study of inherited disease , 1992, Human mutation.

[45]  A. Wintzen,et al.  Diagnostic criteria for Duchenne and Becker muscular dystrophy and myotonic dystrophy , 1991, Neuromuscular Disorders.

[46]  A. Hamosh,et al.  Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis. , 1991, The Journal of clinical investigation.

[47]  S. Burden,et al.  Dystrophin is a component of the subsynaptic membrane , 1991, The Journal of cell biology.

[48]  R. Gibbs,et al.  Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms. , 1991, American journal of human genetics.

[49]  J. Lupski,et al.  Is the carboxyl‐terminus of dystrophin required for membrane association? A novel, severe case of duchenne muscular dystrophy , 1991, Annals of neurology.

[50]  D. Bentley,et al.  Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. , 1991, American journal of human genetics.

[51]  H Sugita,et al.  Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. , 1991, American journal of human genetics.

[52]  D. Bulman,et al.  Point mutation in the human dystrophin gene: identification through western blot analysis. , 1991, Genomics.

[53]  H. Nishio,et al.  Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy kobe. , 1991, The Journal of clinical investigation.

[54]  D. Bentley,et al.  Direct diagnosis of carriers of Duchenne and Becker muscular dystrophy by amplification of lymphocyte RNA , 1990, The Lancet.

[55]  A. Chapelle,et al.  Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies , 1990, Cell.

[56]  S. Bar,et al.  A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution. , 1990, The Biochemical journal.

[57]  L. Maquat,et al.  Translation to near the distal end of the penultimate exon is required for normal levels of spliced triosephosphate isomerase mRNA , 1990, Molecular and cellular biology.

[58]  K. Davies,et al.  Characterization of deletions in the dystrophin gene giving mild phenotypes. , 1990, American journal of medical genetics.

[59]  H. Nishio,et al.  A very small frame-shifting deletion within exon 19 of the Duchenne muscular dystrophy gene. , 1990, Biochemical and biophysical research communications.

[60]  J. Riley,et al.  A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones. , 1990, Nucleic acids research.

[61]  M. W. Thompson,et al.  Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation. , 1990, American journal of human genetics.

[62]  L. Kunkel,et al.  Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. , 1990, The Journal of biological chemistry.

[63]  S. Berget,et al.  Exon definition may facilitate splice site selection in RNAs with multiple exons. , 1990, Molecular and cellular biology.

[64]  C. van Broeckhoven,et al.  Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. , 1989, American journal of human genetics.

[65]  T. Sekiya,et al.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.

[66]  M. Bobrow,et al.  Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy. , 1989, Journal of medical genetics.

[67]  M. W. Thompson,et al.  Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. , 1989, American journal of human genetics.

[68]  A. Beaudet,et al.  Molecular definition of bovine argininosuccinate synthetase deficiency. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[69]  L. Chasin,et al.  Nonsense mutations in the dihydrofolate reductase gene affect RNA processing , 1989, Molecular and cellular biology.

[70]  E A Barnard,et al.  The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. , 1989, Science.

[71]  G. Sarkar,et al.  Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity. , 1989, Science.

[72]  L. Kunkel,et al.  Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus , 1989, Nature.

[73]  J. Concordet,et al.  Illegitimate transcription: transcription of any gene in any cell type. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[74]  D. Bentley,et al.  Rapid carrier and prenatal diagnosis of Duchenne and Becker muscular dystrophy. , 1989, Nucleic acids research.

[75]  L. Kunkel,et al.  Complementary DNA probes for the Duchenne muscular dystrophy locus demonstrate a previously undetectable deletion in a patient with dystrophic myopathy, glycerol kinase deficiency, and congenital adrenal hypoplasia. , 1989, The Journal of clinical investigation.

[76]  R A Gibbs,et al.  Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. , 1988, Nucleic acids research.

[77]  M. W. Thompson,et al.  Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. , 1988, Science.

[78]  U. Francke,et al.  Myopathy in complex glycerol kinase deficiency patients is due to 3' deletions of the dystrophin gene. , 1988, American journal of human genetics.

[79]  Jamel Chelly,et al.  Transcription of the dystrophin gene in human muscle and non-muscle tissues , 1988, Nature.

[80]  R. D. Campbell,et al.  Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[81]  A. Monaco,et al.  The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein , 1988, Cell.

[82]  K. Fischbeck,et al.  Duchenne muscular dystrophy gene expression in normal and diseased human muscle. , 1988, Science.

[83]  R. Gibbs,et al.  Expression of the murine Duchenne muscular dystrophy gene in muscle and brain. , 1988, Science.

[84]  A. Monaco,et al.  An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. , 1988, Genomics.

[85]  Marvin B. Shapiro,et al.  RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. , 1987, Nucleic acids research.

[86]  M. Koenig,et al.  Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals , 1987, Cell.